From: Human papillomavirus infection in patients with laryngeal carcinoma
Chemotherapeutic Agent | Dose | Days | |
---|---|---|---|
Group 1 (Induction CR + CRT) | |||
Induction Chemotherapya | Cisplatin | 75 mg/m2 | 1st |
Docetaxel | 75 mg/m2 | 1st | |
5-FU | 750 mg/m2 | 1st-5th | |
Concomitant Chemotherapyb | Cisplatin | 75 mg/m2 | Once in 7 days |
Group 2 (CRT) | |||
Concomitant Chemotherapyb | Cisplatin | 75 mg/m2 | Once in 7 days |